Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Oktober 2020 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present Update During the 2020 BIO Investor Forum Digital Event

NEWTOWN, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today...
21. September 2020 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals

Company remains on track to file a US IND in Q4 2020, with commencement of a US Phase 1 study targeted for Q1 2021 NEWTOWN, Pa., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc....
09. September 2020 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Participation at Upcoming Virtual Events

NEWTOWN, Pa., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today...
31. August 2020 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Election of James J. Marino, JD, MBA as Chairman of the Board of Directors

NEWTOWN, Pa., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today...
24. August 2020 07:30 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Topline Results from the Pivotal Phase 3 INSPIRE Trial

IV rigosertib did not meet primary endpoint of significantly improved survival versus best supportive care in higher-risk myelodysplastic syndromes (HR-MDS) Onconova will focus on promising...
12. August 2020 16:05 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results

INSPIRE Phase 3 trial survival events reachedTopline data anticipated Q3-2020 Conference call and webcast scheduled today, August 12, at 4:30 p.m. ET NEWTOWN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE)...
07. August 2020 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020

NEWTOWN, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
04. August 2020 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement

NEWTOWN, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
29. Juli 2020 13:30 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis

NEWTOWN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat...
27. Juli 2020 08:00 ET | Quelle: Onconova Therapeutics, Inc.

Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease

Preclinical experiments with rigosertib in cellular models demonstrate marked inhibition of SARS-CoV-2 replication NEWTOWN, Pa., July 27, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc....

Vorherige Seite